For the year ending 2025-12-31, ALTO had -$10,538K decrease in cash & cash equivalents over the period. $8,648K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Consolidated net income (loss) | 13,338 |
| Depreciation and amortization of intangibles | 25,216 |
| Asset impairments | 803 |
| Transferable tax credits, net, generated | 7,500 |
| Inventory valuation | 1,007 |
| Losses (gains) on derivative instruments | 8,068 |
| Amortization of deferred financing costs | 1,013 |
| Amortization of debt discounts | 801 |
| Stock-based compensation | 3,022 |
| Credit loss expense (recovery) | 53 |
| Accounts receivable | -3,314 |
| Inventories | 12,615 |
| Other current assets | -2,279 |
| Operating leases | -6,589 |
| Accounts payable and accrued expenses | -2,829 |
| Net cash provided by (used in) operating activities | 13,245 |
| Additions to property and equipment | 4,597 |
| Deferred purchase price payments for eagle alcohol | 2,240 |
| Purchase of kodiak carbonic, net of cash acquired | 7,278 |
| Excess insurance proceeds | 6,688 |
| Net cash used in investing activities | -7,427 |
| Net (payments on) proceeds from kinergys line of credit | -10,091 |
| Principal payments on term debt | 5,000 |
| Preferred stock dividend payments | 1,265 |
| Net cash (used in) provided by financing activities | -16,356 |
| Net decrease in cash, cash equivalents and restricted cash | -10,538 |
| Cash, cash equivalents and restricted cash at beginning of period | 36,211 |
| Cash, cash equivalents and restricted cash at end of period | 25,673 |
Alto Ingredients, Inc. (ALTO)
Alto Ingredients, Inc. (ALTO)